AU2020103917A4 - Method for preparing a 3d printing gradient antibacterial film, product and application thereof - Google Patents

Method for preparing a 3d printing gradient antibacterial film, product and application thereof Download PDF

Info

Publication number
AU2020103917A4
AU2020103917A4 AU2020103917A AU2020103917A AU2020103917A4 AU 2020103917 A4 AU2020103917 A4 AU 2020103917A4 AU 2020103917 A AU2020103917 A AU 2020103917A AU 2020103917 A AU2020103917 A AU 2020103917A AU 2020103917 A4 AU2020103917 A4 AU 2020103917A4
Authority
AU
Australia
Prior art keywords
printing
gradient
several groups
chitosan
mixed solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2020103917A
Inventor
Jingman Li
Shanshan Li
Siying Li
Yan Li
Xinyi WU
Shengkui Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Agricultural University
Original Assignee
Sichuan Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Agricultural University filed Critical Sichuan Agricultural University
Application granted granted Critical
Publication of AU2020103917A4 publication Critical patent/AU2020103917A4/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/06Pectin; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/04Alginic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/05Alcohols; Metal alcoholates
    • C08K5/053Polyhydroxylic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

The application relates to a method for preparing a 3D printing gradient antibacterial film, a product and application thereof, which belongs to the field of microbes. The method comprises the following steps: taking alginic acid and pectin, adding glycerol 5 and distilled water, and performing uniform stirring to obtain several groups of mixed solution I; taking and dissolving chitosan into acetic acid solution to obtain several groups of mixed solution II with gradient concentration; correspondingly adding the several groups of mixed solution II with gradient concentration into the several groups of mixed solution I one to one, and performing uniform stirring to form a colloidal 10 state to obtain several groups of 3D printing raw materials; respectively performing 3D printing by using the several groups of 3D printing raw materials to obtain several films, and sequentially splicing the several films together seamlessly according to the mass fraction of chitosan; soaking the film in CaCl 2, and performing drying to obtain a 3D printing gradient antibacterial film. The 3D printing gradient antibacterial film 15 provided by the application can be used to observe the movement trajectories of microbial strains. 1/1 FIG.1 FIG.2 FIG.3

Description

1/1
FIG.1
FIG.2
FIG.3
METHOD FOR PREPARING A 3D PRINTING GRADIENT ANTIBACTERIAL FILM,
PRODUCT AND APPLICATION THEREOF
Technical Field
The application belongs to the field of microbes, in particular to a method for preparing a 3D
printing gradient antibacterial film, a product and application thereof.
Background Art
It is one of the most basic skills of living beings to perceive the external environment and
guide their movement. More and more experimental data show that microbial strains can
actively respond to external stimulation, such as light, electricity, compound and oxygen.
Their migration along the direction of the gradient of the concentration of a compound is
called as chemotaxis.
In the past, the study on the movement of microbial strains realized the swimming mode of
the microbial strains in the bacterial suspension by means of biological convection, or
migration along the direction of the gradient of the concentration of the compound. The
movement of the microbial strains is driven by the power produced through the rotation of
one flagellum or a bundle of flagellums with length of about 10um. In a liquid culture
medium, the microbial strains will accumulate on the surface of the culture medium. Usually,
the specific gravity of the microbial strains is slightly larger than that of water, resulting in a
density distribution of "heavy top and light bottom". When the instability accumulates to a
certain extent, the upper fluid will suddenly fall down at a certain point, and absorb the nearby
upper fluid to form a downward flow channel, thus causing biological convection. However,
the movement of the microbial strains caused by biological convection is caused by the
influence of the gravity gradient of the microbial strains, which can only be observed by
macroscopic phenomena in the liquid culture medium. When the microbial strains encounter a
compound that is harmful to them, they will stay away from it. Therefore, in the prior art,
compounds with gradient concentration in liquid can only be used to explore the tactic movement of the microbial strains in the liquid culture medium. Both the movement of the microbial strains and the fluidization of the liquid culture medium will make it difficult to observe the movement states of the microbial strains or make the observation effect not good.
In conclusion, in view of the problems of the prior art, an antibacterial film which facilitates
the observation of the movement states of the microbial strains needs to be studied.
Summary
The purpose of the application is to provide a method for preparing a 3D printing gradient
antibacterial film, a product and application thereof, so as to improve the observability of the
movement states of microbial strains.
The application adopts the following technical solution: a method for preparing a 3D printing
gradient antibacterial film includes the following steps:
(1) taking alginic acid and pectin, adding glycerol and distilled water, and performing uniform
stirring to obtain several groups of mixed solution I with the same concentration;
(2) taking and dissolving chitosan into acetic acid solution to obtain several groups of mixed
solution II with gradient concentration of chitosan;
(3) correspondingly adding the several groups of mixed solution II into the several groups of
mixed solution I one to one, and performing uniform stirring to form a colloidal state to
obtain several groups of 3D printing raw materials with gradient concentration of chitosan;
(4) respectively performing 3D printing by using the several groups of 3D printing raw
materials to obtain several films, sequentially splicing the several films together seamlessly
according to the gradient concentration of chitosan from low to high, soaking the film in
CaCl2 solution, taking out the film, and then performing drying to obtain a 3D printing
gradient antibacterial film.
Preferably, in step (1), the mass ratio of alginic acid to pectin to glycerol to distilled water is
1-2:1-3:0.2-0.4:90-100.
Preferably, in step (2), the mass fraction of the acetic acid solution is 1-2%, the range of the gradient mass fraction of chitosan in the mixed solution II is 0-20%, and a difference between the mass fractions of chitosan in the mixed solution II with adjacent gradient concentration is
4-5%. The mass fraction of chitosan may be 0, since the antibacterial film is formed by
splicing several groups of films with gradient concentration of chitosan. Therefore, when the
mass fraction of one group of chitosan is zero, it does not affect the property that the whole
antibacterial film has gradient concentration.
Preferably, in step (3), the 3D printing parameters are as follows: the printing speed
30-50mm/s, the nozzle aperture is 0.5-0.7mm, the filling rate 80-100%, the wall thickness
1.0-1.4mm. The specific 3D printing parameters may be adjusted adaptively based on the
thickness and size of the required film according to the prior art.
Preferably, in step (4), the mass fraction of the CaCl2 solution is 1-3%, the time of soaking is
3-5min, the temperature of drying is 30-40°C, and the time of drying was 2-3h. The properties
of the film are more stable by soaking in the CaCl2 solution.
Preferably, application of the 3D printing gradient antibacterial film to observation of
movement states of microbial strains includes the following steps:
(1) taking and dissolving a culture of to-be-detected bacteria in NaCl solution with mass
fraction of 0.7-0.9% to obtain a concentrated bacterial suspension with turbidity of
10-20MCF;
(2) weighing and dissolving agar powder in NaCl solution with mass fraction of 0.7-0.9% to
obtain a semi-solid culture medium;
(3) performing high-temperature sterilization to the semi-solid culture medium for 15-20min
at 120-125°C, and then performing ultraviolet sterilization for 20-30min;
(4) under an aseptic operation condition, cooling the semi-solid culture medium prepared in
step (3) to 50-60°C, pouring the semi-solid culture medium into a culture dish, then
inoculating the concentrated bacterial suspension, and performing uniform mixing;
(5) putting the 3D printing gradient antibacterial film into the culture dish prepared in step (4)
to obtain an experimental group, and repeating steps (1)-(4) to obtain a blank group without the 3D printing gradient antibacterial film;
(6) placing and culturing the experimental group and the blank group prepared in step (5) at
35-37°C, and observing the turbidity change of the culture medium every 3-4h;
(7) observing the diameter of turbidity change areas in the experimental group and the blank
group by using a phase contrast microscope, and observing movement forms of microbial
strain cells with the blank group as reference.
Preferably, in step (2), the mass fraction of the agar powder in the semi-solid culture medium
is 0.2-0.7%.
Preferably, in step (4), the volume ratio of the semi-solid culture medium to the concentrated
bacterial suspension is 200-400:1-3.
The prior art does not use the 3D printing technology to explore the movement behavior of
the microbial strains. In the fields of 3D printing and microbes, the past research on the tactic
behavior of the microbial strains mainly includes chemotaxis, phototaxis, geotaxis,
magnetotaxis, oxytaxis, etc. What is adopted in the application is glycotaxis. The chemotaxis
of the microbial strains to amino acids and saccharides are regulated by receptor proteins
located on cell surfaces, and signals are transmitted by intracellular molecules, which
ultimately affect the movement of the microbial strains. The output signals of tactic behaviors
are the movement direction of the microbial strains, which indicates that the determinant of
the movement states is the propeller, i.e., flagellum of the microbial strains.
In the application, the semi-solid culture medium is used and a gradient film is prepared to
study the movement behavior of the microbial strains, which abandons the traditional method
of studying the tactic movement of the microbial strains by using the compound with gradient
concentration only in the liquid culture medium. Since chitosan with polycations attracts the
negative charges on the cell membranes of the microbial strains, which will lead to the
leakage of intracellular protease, we use chitosan as an antibacterial gradient film to study the
taxis of the microbial strains, which is not available in the prior art. The microbial strains will
instinctively stay far away from the substances harmful to them. By adding the gradient film
unfavorable to the microbial strains into the semi-solid culture medium, the movement behavior of the microbial strains can be observed.
The thickness, size and shape of the film can be accurately controlled through 3D printing,
which is incomparable with traditional tape casting and electrospinning. 3D printing uses a
melt extrusion technology to print the prepared printing materials according to the original
path through preset model parameters, which can realize the uniformity of quantity, size and
shape, is highly efficient and can save time. The gradient of the film can be realized by
replacing different gradient printing materials and printing paths. If the same materials are
used to prepare the film by adopting tape casting, firstly, the process of film preparation is
time-consuming and the size and shape of the film cannot be controlled; secondly, the shape is
single and unchanged; finally, the gradient of the film cannot be realized. In the application,
sodium alginate and pectin may be used as printing substrates, and the antibacterial gradient
of the printing substrates can be realized by adding chitosan with different gradient
concentration. Chitosan has polycations, which will attract the negative charges on the cell
membranes of the microbial strains, but the microbial strains will instinctively stay far away
from the compounds that are harmful to them. The gradient film prepared by adopting 3D
printing can be used to study the influence on the movement behavior of the microbial strains,
and thus the movement states of the microbial strains can be observed.
The application has the following beneficial effects:
(1) The 3D printing antibacterial film with gradient concentration prepared in the application,
based on the response principle of the microbes to external environment stimulation, can be
used to observe the movement states of the strains through the chemotactic response of the
strains to chitosan with different concentration.
(2) The polycations of chitosan used in the application interact with the negative charges on
the cell membranes of the microbial strains, which causes the leakage of protease and other
components in the cells, thus achieving the antibacterial and bactericidal effects. Furthermore,
the higher the gradient concentration of chitosan is, the more the microbial strains adsorbed
by the cations, the less the microbial strains escape, the movement of the microbial strains is
inhibited, the turbidity is clearer microscopically, and thus the movement trajectories of the microbial strains can be observed.
(3) In the application, the 3D printing gradient antibacterial film is used to explore the
movement behavior of the microbial strains. By studying the glycotaxis of the microbial
strains, the chemotaxis of the microbial strains to amino acids and saccharide compounds is
regulated by receptor proteins located on cell surfaces, and signals are transmitted by
intracellular molecules, which ultimately affect the movement of the microbial strains.
Chitosan with an antibacterial effect is used to explore the taxis of the microbial strains, such
that the movement states of the microbial strains can be observed.
Description of the Drawings
FIG1 illustrates a 3D printing gradient antibacterial film.
FIG 2 illustrates turbidity diameter changes of Escherichia coli in a semi-solid culture
medium in an experimental group and a blank group.
FIG 3 illustrates turbidity diameter changes of Saccharomycetes in a semi-solid culture
medium in an experimental group and a blank group.
Description of the Embodiments
The technical solution of the application will be further described below in detail. However,
the scope of protection of the application is not limited to what described below.
Example 1
(1) Alginic acid and pectin were taken, glycerin and distilled water were added, and uniform
stirring was performed to obtain five groups of mixed solution I. The mass ratio of alginic
acid to pectin to glycerol to distilled water was 1:3:0.4:300.
(2) Chitosan was taken and dissolved in acetic acid solution with mass fraction of 2% to
obtain several groups of mixed solution II with gradient mass fraction. The range of the
gradient mass fraction of chitosan in the several groups of mixed solution II was 0-20%, a
difference between the mass fractions of chitosan in the mixed solution II with adjacent
gradient mass fraction was 5%, and the mass fractions were specifically 0, 5%, 10%, 15%, and 20%.
(3) The several groups of mixed solution II prepared in step (2) were correspondingly added
into the several groups of mixed solution I one to one, and uniform stirring was performed to
form a colloidal state to obtain several groups of 3D printing raw materials.
(4) 3D printing was respectively performed by using the several groups of 3D printing raw
materials to obtain several films, the several films were sequentially spliced together
seamlessly according to the gradient mass fraction of chitosan from low to high, the spliced
gradient antibacterial film was soaked for crosslinking for 5min in 3% CaCl2 solution, and
then drying was performed to obtain a 3D printing gradient antibacterial film for observing
the movement states of bacteria.
Setting of 3D printing parameters: a small cube model was selected, a model with parameters
of 1.0*1.5*0.2cm was set on cura software, the printing speed was 50mm/s, the nozzle
aperture was 0.7mm, the filling rate was 100%, and the wall thickness was 1.0-1.4mm.
The specific printing steps were as follows: the 3D printing material prepared in step (3) was
put into a barrel, and an aluminum cover was screwed tightly to complete the filling work;
one end of an air pipe was inserted into a quick plug, and the other end was connected with an
outlet end of a pressure regulating valve; an air valve was opened, and at this time, the
material entered a large sleeve part (aluminum block) of an extruder under the pushing force
of air pressure. A motor was controlled to rotate through a preset program, and the motor
drove a screw to rotate through a coupling and a bearing to accurately control the extrusion of
the material; the model parameters set in advance in step (3) were selected, a "PRINT" button
was clicked, and a 3D printer (ZD-2000A, manufactured by Shenzhen Zhandong Industry Co.,
Ltd.) completed the printing process according to the preset model path.
Method of application:
(1) A culture of Escherichia coli was taken and dissolved in NaCl solution with mass fraction
of 0.9% to obtain a concentrated bacterial suspension with turbidity of 20MCF.
(2) Agar powder was weighed and dissolved in NaCl solution with mass fraction of 0.9% to obtain a semi-solid culture medium. The mass fraction of the agar powder in the semi-solid culture medium was 0.7%.
(3) High-temperature sterilization was performed to the semi-solid culture medium for 20min
at 135°C, and then ultraviolet sterilization was performed for 30min.
(4) Under an aseptic operation condition, the semi-solid culture medium prepared in step (3)
was cooled to 60°C, the semi-solid culture medium was poured into a culture dish, then 100ul
of the concentrated bacterial suspension prepared in step (1) were inoculated, and uniform
mixing was performed. The volume ratio of the semi-solid culture medium to the
concentrated bacterial suspension was 400:3.
(5) The 3D printing gradient antibacterial film was put into the culture dish prepared in step (4)
to obtain an experimental group, and steps (1)-(4) were repeated to obtain a blank group
without the 3D printing gradient antibacterial film.
(6) The experimental group and the blank group prepared in step (5) were placed and cultured
at 37C, and the turbidity change of the film with gradient concentration in the culture
medium was observed every 4h. The diameter of bacterial turbidity change in the gradient
film was 10mm, and the diameter of change in the blank group without the gradient film was
4mm.
(7) The diameter of turbidity change areas in the experimental group and the blank group was
observed by using a phase contrast microscope, and movement forms of bacterial cells were
observed with the blank group as reference.
Referring to FIG. 2, the upper part of the picture represents the range of diffusion of
Escherichia coli in the gradient film. Since Escherichia coli are Gram-negative bacteria, a
peptidoglycan layer in a cell wall is thin and is a two-dimensional plane with loose structure,
when contacting with the chitosan film with gradient concentration, the signals received on
the Escherichia coli film tend to be far away from the gradient film. When observed on the
semi-solid culture medium by using a microscope, it shows that larger turbidity diameter and
faster change speed. The lower part of the picture represents the movement states of
Escherichia coli in the absence of the gradient film. Since the glycotaxis of the microbial strains has a tendency of diffusion to the surrounding nutrients, but the diffusion speed is slow, it shows slow speed of turbidity diameter change and smaller diameter.
Example 2
(1) Alginic acid and pectin were taken, glycerin and distilled water were added, and uniform
stirring was performed to obtain six groups of mixed solution I. The mass ratio of alginic acid
to pectin to glycerol to distilled water was 1:1:0.2:300.
(2) Chitosan was taken and dissolved in acetic acid solution with mass fraction of 2% to
obtain several groups of mixed solution II with gradient mass fraction. The range of the
gradient mass fraction of chitosan in the several groups of mixed solution II was 0-20%, a
difference between the mass fractions of chitosan in the mixed solution II with adjacent
gradient mass fraction was 4%, and the mass fractions were specifically 0, 4%, 8%, 12%,
16%, and 20%.
(3) The several groups of mixed solution II prepared in step (2) were correspondingly added
into the several groups of mixed solution I one to one, and uniform stirring was performed to
form a colloidal state to obtain several groups of 3D printing raw materials.
(4) 3D printing was respectively performed by using the several groups of 3D printing raw
materials to obtain several films, the several films were sequentially spliced together
seamlessly according to the mass fraction of chitosan from low to high, the spliced gradient
antibacterial film was soaked for crosslinking for 3min in 1% CaCl2 solution, and then drying
was performed to obtain a 3D printing gradient antibacterial film for observing the movement
states of bacteria.
Setting of 3D printing parameters: a small cube model was selected, a model with parameters
of 1.0*1.5*0.2cm was set on cura software, the printing speed was 30mm/s, the nozzle
aperture was 0.5mm, the filling rate was 80%, and the wall thickness was 1.0mm.
The specific printing steps were the same as that in example 1.
Method of application:
(1) A culture of Staphylococcus aureus was taken and dissolved in NaCl solution with mass fraction of 0.7% to obtain a concentrated bacterial suspension with turbidity of10MCF.
(2) Agar powder was weighed and dissolved in NaCl solution with mass fraction of 0.7% to
obtain a semi-solid culture medium. The mass fraction of the agar powder in the semi-solid
culture medium was 0.2%.
(3) High-temperature sterilization was performed to the semi-solid culture medium for 15min
at 121°C, and then ultraviolet sterilization was performed for 20min.
(4) Under an aseptic operation condition, the semi-solid culture medium prepared in step (3)
was cooled to 50°C, the semi-solid culture medium was poured into a culture dish, then 50ul
of the concentrated bacterial suspension prepared in step (1) were inoculated, and uniform
mixing was performed. The volume ratio of the semi-solid culture medium to the
concentrated bacterial suspension was 200:1.
(5) The 3D printing gradient antibacterial film was put into the culture dish prepared in step (4)
to obtain an experimental group, and steps (1)-(4) were repeated to obtain a blank group
without the 3D printing gradient antibacterial film.
(6) The experimental group and the blank group prepared in step (5) were placed and cultured
at 35°C, and the turbidity change of the film with gradient concentration in the culture
medium was observed every 4h. The diameter of bacterial turbidity change in the gradient
film was 5mm, and the diameter of change in the blank group without the gradient film was
2mm.
(7) The diameter of turbidity change areas in the experimental group and the blank group was
observed by using a phase contrast microscope, and movement forms of bacterial cells were
observed with the blank group as reference.
The turbidity diameter change of Staphylococcus aureus on the gradient film is smaller than
that of Escherichia coli. Staphylococcus aureus are Gram-positive bacteria, and a
peptidoglycan layer on a cell wall is thick and is a solid three-dimensional network structure.
The signals that the chemical receptors on the cell membrane surfaces receive the gradient
chitosan stimulation are weak, so the flagella of the microbial strains move slowly, and the range of movement toward the surround is small. Under a microscope, the turbidity diameter is small and the change speed is slow.
Example 3
(1) Alginic acid and pectin were taken, glycerin and distilled water were added, and uniform
stirring was performed to obtain five groups of mixed solution I. The mass ratio of alginic
acid to pectin to glycerol to distilled water was 1:2:0.3:300.
(2) Chitosan was taken and dissolved in acetic acid solution with mass fraction of 1.4% to
obtain several groups of mixed solution II with gradient mass fraction. The range of the
gradient mass fraction of chitosan in the several groups of mixed solution II was 0-20%, a
difference between the mass fractions of chitosan in the mixed solution II with adjacent
gradient mass fraction was 5%, and the mass fractions were specifically 0, 5%, 10%, 15%,
and 20%.
(3) The several groups of mixed solution II prepared in step (2) were correspondingly added
into the several groups of mixed solution I one to one, and uniform stirring was performed to
form a colloidal state to obtain several groups of 3D printing raw materials.
(4) 3D printing was respectively performed by using the several groups of 3D printing raw
materials to obtain several films, the several films were sequentially spliced together
seamlessly according to the gradient mass fraction of chitosan from low to high, the spliced
gradient antibacterial film was soaked for crosslinking for 4min in 3% CaCl2 solution, and
then drying was performed to obtain a 3D printing gradient antibacterial film for observing
the movement states of bacteria.
Setting of 3D printing parameters: a small cube model was selected, a model with parameters
of 1.0*1.5*0.2cm was set on cura software, the printing speed was 35mm/s, the nozzle
aperture was 0.6mm, the filling rate was 90%, and the wall thickness was 1.2mm.
The specific printing steps were the same as that in example 1.
Method of application:
(1) A culture of Saccharomycetes was taken and dissolved in NaCl solution with mass fraction of 0.8% to obtain a concentrated bacterial suspension with turbidity of 15MCF.
(2) Agar powder was weighed and dissolved in NaCl solution with mass fraction of 0.8% to
obtain a semi-solid culture medium. The mass fraction of the agar powder in the semi-solid
culture medium was 0.5%.
(3) High-temperature sterilization was performed to the semi-solid culture medium for 17min
at 128°C, and then ultraviolet sterilization was performed for 25min.
(4) Under an aseptic operation condition, the semi-solid culture medium prepared in step (3)
was cooled to 56°C, the semi-solid culture medium was poured into a culture dish, then 70ul
of the concentrated bacterial suspension prepared in step (1) were inoculated, and uniform
mixing was performed. The volume ratio of the semi-solid culture medium to the
concentrated bacterial suspension was 150:1.
(5) The 3D printing gradient antibacterial film was put into the culture dish prepared in step (4)
to obtain an experimental group, and steps (1)-(4) were repeated to obtain a blank group
without the 3D printing gradient antibacterial film.
(6) The experimental group and the blank group prepared in step (5) were placed and cultured
at 36°C, and the turbidity change of the film with gradient concentration in the culture
medium was observed every 3h. The diameter of Saccharomycetes turbidity change in the
gradient film was 6mm, and the diameter of change in the blank group without the gradient
film was 3mm.
(7) The diameter of turbidity change areas in the experimental group and the blank group was
observed by using a phase contrast microscope, and movement forms of bacterial cells were
observed with the blank group as reference.
Referring to FIG. 3, the turbidity diameter change of Saccharomycetes in the gradient film is
greater than that in the blank group. Saccharomycetes are eukaryotic microbes. After
receiving the stimulation of gradient chitosan, the specific chemical receptors on the fungal
cell membranes do not respond as violently as Escherichia coli and diffuse rapidly around.
After receiving the stimulation signal of chitosan, information is transmitted to the cytoproteins in the cells. The intracellular proteins control the movement of flagella, such that the microbial strains diffuse around. The transmission speed of the stimulation signals from the outside of the cells to the flagella is slower than the transmission speed of the microbial strains. Therefore, the turbidity diameter is smaller than that of Escherichia coli, and the change speed is relatively slower.
In the application, by adopting the method of combining 3D printing of the antibacterial film
with gradient concentration and the response of microbes to external environment stimulation,
the chemotactic response of different strains (Escherichia coli, Staphylococcus aureus and
Saccharomycetes) to chitosan with different concentration is studied. Escherichia coli and
Staphylococcus aureus are respectively the representatives of Gram-negative bacteria and
Gram-positive bacteria, Saccharomycetes are the representative of eukaryotic microbes, and
Saccharomycete can be used to compare the different influence of the 3D printed gradient
film on the movement behavior of bacteria and fungi.
According to the chemotactic response of Escherichia coli, Staphylococcus aureus and
Saccharomycete to chitosan with different concentration, the results show that the movement
trajectory of Escherichia coli is more obvious than that of the other two kinds of bacteria.
Since the cell wall of Gram-negative bacteria is a two-dimensional plane with loose structure,
the stimulation response to chitosan with polycations is fiercer, the tendency that the bacteria
escape from the gradient film is more obvious, and the movement trajectory is larger and
more obvious.
What are described above are just preferred implementation modes of the application. It
should be understood that the application is not limited to the modes disclosed herein, and
should not be regarded as excluding other embodiments, but may be used for various other
combinations, modifications and environments, and may be modified through the
above-mentioned teaching or technology or knowledge in the related art within the scope of
the concept described herein. However, any modifications and changes made by those skilled
in the art without departing from the spirit and scope of the application shall fall within the
scope of protection defined by the attached claims of the application.

Claims (5)

1. A method for preparing a 3D printing gradient antibacterial film, wherein the
method comprises the following steps:
(1) taking alginic acid and pectin, adding glycerol and distilled water, and performing
uniform stirring to obtain several groups of mixed solution I with the same
concentration;
(2) taking and dissolving chitosan into acetic acid solution to obtain several groups of
mixed solution II with gradient concentration of chitosan;
(3) correspondingly adding the several groups of mixed solution II into the several
groups of mixed solution I one to one, and performing uniform stirring to form a
colloidal state to obtain several groups of 3D printing raw materials with gradient
concentration of chitosan;
(4) respectively performing 3D printing by using the several groups of 3D printing
raw materials to obtain several films, sequentially splicing the several films together
seamlessly according to the gradient concentration of chitosan from low to high,
soaking the film in CaCl 2 solution, taking out the film, and then performing drying to
obtain a 3D printing gradient antibacterial film.
2. The method according to claim 1, wherein in step (1), the mass ratio of alginic
acid to pectin to glycerol to distilled water is 1-2:1-3:0.2-0.4:90-100;
wherein in step (2), the mass fraction of the acetic acid solution is 1-2%, the range of
the gradient mass fraction of chitosan in the mixed solution II is 0-20%, and a
difference between the mass fractions of chitosan in the mixed solution II with
adjacent gradient concentration is 4-5%;
wherein in step (4), the mass fraction of the CaCl 2 solution is 1-3%, the time of
soaking is 3-5min, the temperature of drying is 30-40°C, and the time of drying was
2-3h.
3. A 3D printing gradient antibacterial film prepared by adopting the method
according to any one of claims 1-2.
4. Application of the 3D printing gradient antibacterial film according to claim 3 to
observation of movement states of microbial strains.
5. The application of the 3D printing gradient antibacterial film to observation of
movement states of microbial strains according to claim 4, wherein the application
comprises the following steps:
(1) taking and dissolving a culture of to-be-detected bacteria in NaCl solution with
mass fraction of 0.7-0.9% to obtain a concentrated bacterial suspension with turbidity
of 10-20MCF;
(2) weighing and dissolving agar powder in NaCl solution with mass fraction of
0.7-0.9% to obtain a semi-solid culture medium;
(3) performing high-temperature sterilization to the semi-solid culture medium for
-20min at 120-125°C, and then performing ultraviolet sterilization for 20-30min;
(4) under an aseptic operation condition, cooling the semi-solid culture medium
prepared in step (3) to 50-60°C, pouring the semi-solid culture medium into a culture
dish, then inoculating the concentrated bacterial suspension, and performing uniform
mixing;
(5) putting the 3D printing gradient antibacterial film into the culture dish prepared in
step (4) to obtain an experimental group, and repeating steps (1)-(4) to obtain a blank
group without the 3D printing gradient antibacterial film;
(6) placing and culturing the experimental group and the blank group prepared in step
(5) at 35-37°C, and observing the turbidity change of the culture medium every 3-4h;
(7) observing the diameter of turbidity change areas in the experimental group and the
blank group by using a phase contrast microscope, and observing movement forms of
microbial strain cells with the blank group as reference; wherein in step (2), the mass fraction of the agar powder in the semi-solid culture medium is 0.2-0.7%; wherein in step (4), the volume ratio of the semi-solid culture medium to the concentrated bacterial suspension is 200-400:1-3.
AU2020103917A 2019-12-10 2020-12-07 Method for preparing a 3d printing gradient antibacterial film, product and application thereof Ceased AU2020103917A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911254842.9A CN111138723B (en) 2019-12-10 2019-12-10 Preparation method of 3D printing gradient antibacterial film, product and application thereof
CN201911254842.9 2019-12-10

Publications (1)

Publication Number Publication Date
AU2020103917A4 true AU2020103917A4 (en) 2021-02-11

Family

ID=70517848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020103917A Ceased AU2020103917A4 (en) 2019-12-10 2020-12-07 Method for preparing a 3d printing gradient antibacterial film, product and application thereof

Country Status (2)

Country Link
CN (1) CN111138723B (en)
AU (1) AU2020103917A4 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112406095B (en) * 2020-11-05 2021-09-28 三阳纺织有限公司 Fabric with antibacterial function and rapid forming method thereof
CN112606391B (en) * 2020-11-27 2022-12-09 山东第一医科大学附属省立医院(山东省立医院) Manufacturing method of medical instrument for digestive system department

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919574A (en) * 1995-12-29 1999-07-06 The United States Of America, As Represented By The Secretary Of Agriculture Biodegradable laminated films fabricated from pectin and chitosan
CN1297957A (en) * 1999-12-01 2001-06-06 武汉大学 Preparation and use of intermingled film or fiber of carboxymethyl chitosan and alginic acid
CN100413919C (en) * 2002-12-13 2008-08-27 上海爱普食品工业有限公司 Method for preparing composite comestible shell polysaccharide membrane
CN100336564C (en) * 2005-02-02 2007-09-12 江汉大学 Burn dressing of chitin gel with gradient structure and its preparation
CN100475886C (en) * 2007-03-29 2009-04-08 浙江大学 Method for preparing polymer material with gradient distributed surface biomacromolecule
CN101955984A (en) * 2010-09-30 2011-01-26 浙江大学 Method for detecting optimal density and time for bacterium suppression of chitosan
WO2016132182A1 (en) * 2015-02-20 2016-08-25 Cells For Cells Devices for studying chemotaxis/adherence in cells wherein gradients and channels are formed using hydrogels
CN105199113B (en) * 2015-09-16 2017-10-17 盐城工学院 A kind of preparation method of alternately stratiform chitosan/alginic acid compound hydrogel material
CN108310454B (en) * 2018-03-20 2020-04-17 山东大学 Gradient biological ceramic material coated with gelatin/chitosan composite porous membrane and preparation method thereof
CN108715816A (en) * 2018-04-12 2018-10-30 暨南大学 A method of induction aimed strain forms chemotactic ring on semisolid tablet
CN109529099B (en) * 2018-11-27 2022-01-14 浙江海洋大学 Double-network chitosan enzyme-loaded hydrogel dressing based on three-dimensional printing technology and preparation method thereof

Also Published As

Publication number Publication date
CN111138723A (en) 2020-05-12
CN111138723B (en) 2021-07-20

Similar Documents

Publication Publication Date Title
AU2020103917A4 (en) Method for preparing a 3d printing gradient antibacterial film, product and application thereof
Topiwala et al. Effect of wall growth in steady‐state continuous cultures
Mormino et al. Composites of bacterial cellulose and paper made with a rotating disk bioreactor
CN201626960U (en) Perfusion device for stem cell culture
JP5922672B2 (en) Bioreactor with lid for easy access to incubation cavity
CN100360657C (en) Horizontal drum type bioreactor
Wang et al. Accumulation mechanism of biofilm under different water shear forces along the networked pipelines in a drip irrigation system
Pan et al. Effects of hydrodynamic conditions on the composition, spatiotemporal distribution of different extracellular polymeric substances and the architecture of biofilms
CN104927546B (en) A kind of preparation method of marine microorganism antifouling coating
Deforet Long‐range alteration of the physical environment mediates cooperation between Pseudomonas aeruginosa swarming colonies
WASE et al. Variations in the volumes of microbial cells with change in the agitation rates of chemostat cultures
Breguet et al. CHO immobilization in alginate/poly-L-lysine microcapsules: an understanding of potential and limitations
CN102787069B (en) Diatom growth variable research system based on square diatom culture frame
Oh et al. Control of temperature dependence of microbial time–temperature integrator (TTI) by microencapsulation of lactic acid bacteria into microbeads with different proportions of alginate
US10301665B2 (en) Device and method for dispensing a suspension of microorganisms
CN106315789A (en) Sterilization composition for microbial pollution of industrial water system
Kichouh-Aiadi et al. CFD-based prediction of initial microalgal adhesion to solid surfaces using force balances
CN215328005U (en) Liquid guiding device of microorganism culture instrument
Iborra et al. Immobilization in carrageenans
Makowski et al. Live-cell imaging of the life cycle of bacterial predator Bdellovibrio bacteriovorus using time-lapse fluorescence microscopy
CN205046127U (en) System for open pond through little algae of pH value control and add carbon dioxide
DE102010013852A1 (en) Process for the process control of a reactant-limited, biochemical reaction
Frénod et al. An explanatory model to validate the way water activity rules periodic terrace generation in Proteus mirabilis swarm
CN220999635U (en) Microorganism constant temperature culture apparatus
CN209816143U (en) Simple and easy device of cultivateing that expands of non-anaerobic microorganisms

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry